Which antiarrhythmic drug has a metabolite with the same pharmacologic action?

Enhance your knowledge with the Ciulla Clinical Chemistry Test. Study with interactive quizzes, featuring flashcards and multiple-choice questions. Each question offers hints and explanations for better understanding. Prepare effectively and excel in your exam!

Multiple Choice

Which antiarrhythmic drug has a metabolite with the same pharmacologic action?

Explanation:
Some antiarrhythmics are converted into active metabolites that continue to exert the same therapeutic effect. Procainamide is metabolized to N-acetylprocainamide (NAPA), an active metabolite that retains antiarrhythmic activity. NAPA contributes to the overall action by prolonging the action potential duration, mainly through potassium-channel effects, which is a shared aspect of suppressing abnormal rhythms. Because this metabolite remains pharmacologically active, it can influence both efficacy and risk (for example, QT prolongation and torsades de pointes), especially in individuals who acetylate slowly. This is why procainamide is the drug whose metabolite has the same antiarrhythmic action as the parent drug.

Some antiarrhythmics are converted into active metabolites that continue to exert the same therapeutic effect. Procainamide is metabolized to N-acetylprocainamide (NAPA), an active metabolite that retains antiarrhythmic activity. NAPA contributes to the overall action by prolonging the action potential duration, mainly through potassium-channel effects, which is a shared aspect of suppressing abnormal rhythms. Because this metabolite remains pharmacologically active, it can influence both efficacy and risk (for example, QT prolongation and torsades de pointes), especially in individuals who acetylate slowly. This is why procainamide is the drug whose metabolite has the same antiarrhythmic action as the parent drug.

Subscribe

Get the latest from Examzify

You can unsubscribe at any time. Read our privacy policy